COVID-19 Pandemic Brings Far-reaching Healthcare Consequences and Increased Disease Risk
A new whitepaper discusses how deferred care or a lack of care during the pandemic will drive high healthcare costs [...]
ICER Announces New Governance Board Members in Push to Improve Drug Pricing and Health Equity
ICER (the Institute for Clinical and Economic Review) has announced the election of two members to its Governance Board: Joy [...]
Register Today for ISPOR’s HEOR Education Webinar
ISPOR is hosting a webinar on Tuesday, March 23rd at 11 AM Eastern Time. Join this free event to learn [...]
Will States Look to ICER Reports in Legislative Measures to Regulate Drug Prices?
High drug prices are a national crisis. Policymakers in three different states (Washington, Maine, and Hawaii) have introduced price control [...]
How Do Bioisimilars Drive High Drug Prices? Proposed Drug Policy Could Save Americans $360 Billion
One proposed solution for high drug prices in the United States is the use of biosimilars. According to Peter Bach, [...]
Democratic and Republican Voters Agree on Lowering Extreme Drug Prices
A recent poll suggests that President Biden needs to take firm action on skyrocketing prescription drug prices. Prescription drug price [...]
Will Washington State Take on Drug Distribution Role?
A new bill would give the state of Washington’s Health Care Authority the power to distribute generic drugs and insulin [...]
Pfizer Executive Confident in COVID-19 Vaccine Price Increase, $175 per Dose Possible
Pfizer CFO Frank D’Amelio spoke about the outlook for the company’s COVID-19 vaccine. He’s confident that the current price of [...]
The Impact of COVID-19 on Pharma Sales Representatives
As the COVID-19 pandemic continues, the typical day-to-day life of a pharma sales rep has drastically changed. Visiting hospitals to [...]
ICER Adds Members to Three Appraisal Councils to Boost Evidence Reviews
ICER (the Institute for Clinical and Economic Review) has added members to three independence appraisal councils: Midwest CEPAC (Midwest Comparative [...]
Cytel Webinar on Effectively Using RWD in Clinical Trials
The use of RWD (real world data) is on the rise. However, certain myths regarding when and how it can [...]
How Will Sale and Distribution of Generic Drugs in Washington State Affect Drug Prices?
Surging drug prices have led to widespread frustration across the United States. Washington state’s Senate recently passed drug pricing legislation [...]
PRMA Consulting Offers Insight Into US Drug Market and ICER Recommendations
PRMA Consulting has released an eBook detailing the major issues faced by pharmaceutical companies in the United States. Access to [...]
Panacea and IQVIA Host RWE and HEOR Webinar on Saturday, March 20th
A webinar on RWE (real world evidence) and HEOR (health economics and outcomes research) will take place on March 20th [...]
Syneos Health Communications Adds Three Senior Hires to Team
Syneos has added three high-profile hires to their team. Orrin Pollard will take on the role of Director of European [...]
ICER to Investigate Treatments for Autoimmune Disease Myasthenia Gravis
ICER will determine the efficacy and economic outcomes of two treatments for autoimmune disease Myasthenia Gravis where neuromuscular junctions are [...]
Workforce Requires Training to Bolster Value-Based Care and Healthcare Equity
Value-based care and equity require several healthcare components to be improved and expanded upon, including the development of the workforce. [...]
Using Analytics to Understand Value-Based Pricing During COVID-19
Value-based prescription drug pricing agreements are increasing for many expensive and complex drugs. However, these agreements are becoming less used [...]
Whitepaper on Artificial Intelligence and Machine Learning in Clinical Trials
Medical imaging data obtained during clinical trials contains valuable data. As pharmaceutical companies consider using time-saving and efficient artificial intelligence [...]
How Will Loss of Exclusivity Affect Drug Prices?
Ten drugs are expected to lose their exclusivity this year, including Roche’s Lucentis for macular degeneration. Other companies, such as [...]
IQVIA Partners with Janssen R & D on COVID-19 Vaccine Trial, RWD To Be Utilized in Phase 3 Trial
IQVIA has announced a partnership with Janssen Research & Development, LLC. They will work together to carry out a Phase [...]
McKesson and Vanderbilt Health Rx Solutions Form Partnership to Offer Specialty Pharmacy Consulting Service
McKesson Corporation reported a partnership with VHRxS (Vanderbilt Health Rx Solutions). VHRxS it a national company owned by Vanderbilt University [...]
NHLBI and ACC Announce Innovation Showcase on April 1st Featuring Many Exciting Cardiovascular Startups
The NHLBI (National Heart, Lung, and Blood Institute) and ACC (American College of Cardiology) have partnered to host the very [...]
Webinar on RWE in Drug Development and FDA Guidelines, RWE Used in 75% of FDA Approvals Last Year
A new webinar features insight from key leaders at Aetion, Sanofi, and Janssen. They discuss the impacts of RWE (real [...]
ISPOR’s Inaugural Event on Next Generation Innovation Kicks off April 27th
ISPOR has begun a new program on next generation innovation called 'Signal' that provides insight into healthcare decisions in the [...]